Advertisement

April 22, 2020

Cerus Endovascular’s Neqstent Coil-Assisted Flow Diverter Approved in Europe

April 22, 2020—Cerus Endovascular Ltd. announced that it has received European CE Mark approval for its Neqstent coil-assisted flow diverter device to treat intracranial aneurysms. Commercial sales, via a controlled market release across the European Union, are expected to begin during the fourth quarter of 2020.

According to the company, the Neqstent is designed to treat a range of aneurysm morphologies, including wide-necked bifurcation and bifurcation aneurysms. The adjunctive intrasaccular flow diverter device provides stable aneurysm neck coverage for the placement of embolization coils within the sac and long-term occlusion of the aneurysm.

The Neqstent is sized only to the aneurysm neck and designed for use in combination with embolization coils. The device maintains the coils inside the aneurysm sac without requiring parent vessel stabilization. Neqstent devices are constructed from a visible super-elastic mesh braid and are delivered and deployed in a similar manner as the Cerus Endovascular’s Contour neurovascular system, stated the company.

Advertisement


April 23, 2020

FDA Clears Cagent Vascular’s Serranator Device for the Infrapopliteal Indication

April 22, 2020

Intact Vascular's Tack Endovascular System (4F) for BTK Arteries Introduced in the United States